A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
PhII ICb With/Without Erbitux in MBC Pts
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment
- Status
- TERMINATED
- Phase
- PHASE4
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
XELOX for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dendritic Cell Based Therapy of Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
- Status
- COMPLETED
- Phase
- PHASE2
Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
- Status
- COMPLETED
- Phase
- PHASE4
Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE4
Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3